System and method for automated detection and monitoring of dysplasia and administration of immunotherapy and chemotherapy
US11069054B2 · kind B2 · utility
0Cited by
202References
4Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 11, 2017 |
| Grant date | Jul 20, 2021 |
| Priority date | — |
| Expiry date | Feb 11, 2038 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG06T2207/30024
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
A method of treating a malignancy in a human subject by analyzing pseudo-projection images of cells obtained from a sputum specimen obtained from a subject employs a biological specimen classifier that identifies cells from the sputum specimen as normal or abnormal. If abnormal cells are detected, then the abnormal cells are further classified as dysplastic or cancerous. If the cells are classified as dysplastic, then an immunomodulating agent is administered to the subject over a predetermined time period designed to achieve a therapeutic dosage.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.